About Us

Pharmalicensing - Partnering solutions for the life sciences

 

Our Products

Overview

Partnering Search

Company Profiling

Deal Negotiation

PL Intelligence

Reports

Comparison

 

PL Intelligence

Overview

Industry news

Deals review

Press releases

Articles

 

Case Studies

See what others think about our service

 

Newsletter

Partnering update

Key reports

Subscribe

 

Quick Links

Profile now

Register now

Profiled companies

Featured events

Industry news

PR Newswire

Jobs

 

Contact Pharmalicensing

Send an email

Call us: +44 1904 520460

Request a callback

 

RSS Feeds

Keep up to date

Novartis launches Prevacid

NOVELOS THERAPEUTICS CLOSES LAST TRANCHE IN $9 MILLION PRIVATE PLACEMENT

The European Commission grants Orphan Drug designation for NGR-hTNF in the treatment of hepatocellular carcinoma

IRONWOOD AND ASTELLAS ANNOUNCE JAPAN LICENSING AGREEMENT FOR LINACLOTIDE

New Phase IIa data on TMC435 in patients with hepatitis C presented at the ongoing AASLD - meeting

Transgene: First Patient enrolled in Phase I Trial of TG4023 for the Treatment of Liver Tumours

Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C Virus Infection, at Liver Meeting 2009

Idenix Pharmaceuticals Initiates Phase II Clinical Trial of IDX184 in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)

IRONWOOD AND FOREST ANNOUNCE POSITIVE LINACLOTIDE RESULTS FROM TWO PIVOTAL PHASE 3 TRIALS IN PATIENTS WITH CHRONIC CONSTIPATION

ORTHO CLINICAL DIAGNOSTICS LAUNCHES FETALSCREEN(TM) II FETAL MATERNAL HEMORRHAGE SCREENING TEST

Clients in focus...